» Articles » PMID: 26578948

Probing Astrocyte Metabolism in Vivo: Proton Magnetic Resonance Spectroscopy in the Injured and Aging Brain

Overview
Specialty Geriatrics
Date 2015 Nov 19
PMID 26578948
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Following a brain injury, the mobilization of reactive astrocytes is part of a complex neuroinflammatory response that may have both harmful and beneficial effects. There is also evidence that astrocytes progressively accumulate in the normal aging brain, increasing in both number and size. These astrocyte changes in normal brain aging may, in the event of an injury, contribute to the exacerbated injury response and poorer outcomes observed in older traumatic brain injury (TBI) survivors. Here we present our view that proton magnetic resonance spectroscopy ((1)H-MRS), a neuroimaging approach that probes brain metabolism within a defined region of interest, is a promising technique that may provide insight into astrocyte metabolic changes in the injured and aging brain in vivo. Although (1)H-MRS does not specifically differentiate between cell types, it quantifies certain metabolites that are highly enriched in astrocytes (e.g., Myo-inositol, mlns), or that are involved in metabolic shuttling between astrocytes and neurons (e.g., glutamate and glutamine). Here we focus on metabolites detectable by (1)H-MRS that may serve as markers of astrocyte metabolic status. We review the physiological roles of these metabolites, discuss recent (1)H-MRS findings in the injured and aging brain, and describe how an astrocyte metabolite profile approach might be useful in clinical medicine and clinical trials.

Citing Articles

Neurodevelopmental Abnormalities in Down Syndrome: Assessing Structural and Functional Deficits.

Robinson J, Chawla N, Patel S, Spey E, McNulty O, Kaur G Cureus. 2025; 16(12):e76156.

PMID: 39845250 PMC: 11750628. DOI: 10.7759/cureus.76156.


Diffusion of brain metabolites highlights altered brain microstructure in type C hepatic encephalopathy: a 9.4 T preliminary study.

Mosso J, Briand G, Pierzchala K, Simicic D, Sierra A, Abdollahzadeh A Front Neurosci. 2024; 18:1344076.

PMID: 38572151 PMC: 10987698. DOI: 10.3389/fnins.2024.1344076.


Alzheimer's Disease-like Pathological Features in the Dorsal Hippocampus of Wild-Type Rats Subjected to Methionine-Diet-Evoked Mild Hyperhomocysteinaemia.

Kovalska M, Hnilicova P, Kalenska D, Adamkov M, Kovalska L, Lehotsky J Cells. 2023; 12(16).

PMID: 37626897 PMC: 10453870. DOI: 10.3390/cells12162087.


Longitudinal changes in brain metabolites in healthy controls and patients with first episode psychosis: a 7-Tesla MRS study.

Wang M, Barker P, Cascella N, Coughlin J, Nestadt G, Nucifora Jr F Mol Psychiatry. 2023; 28(5):2018-2029.

PMID: 36732587 PMC: 10394114. DOI: 10.1038/s41380-023-01969-5.


Astrocytes in the initiation and progression of epilepsy.

Vezzani A, Ravizza T, Bedner P, Aronica E, Steinhauser C, Boison D Nat Rev Neurol. 2022; 18(12):707-722.

PMID: 36280704 PMC: 10368155. DOI: 10.1038/s41582-022-00727-5.


References
1.
Lin A, Ramadan S, Stern R, Box H, Nowinski C, Ross B . Changes in the neurochemistry of athletes with repetitive brain trauma: preliminary results using localized correlated spectroscopy. Alzheimers Res Ther. 2015; 7(1):13. PMC: 4361214. DOI: 10.1186/s13195-015-0094-5. View

2.
Terpstra M, Henry P, Gruetter R . Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference-edited spectra. Magn Reson Med. 2003; 50(1):19-23. DOI: 10.1002/mrm.10499. View

3.
Brooks W, Friedman S, Stidley C . Reproducibility of 1H-MRS in vivo. Magn Reson Med. 1999; 41(1):193-7. DOI: 10.1002/(sici)1522-2594(199901)41:1<193::aid-mrm27>3.0.co;2-p. View

4.
Pellerin L, Magistretti P . Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A. 1994; 91(22):10625-9. PMC: 45074. DOI: 10.1073/pnas.91.22.10625. View

5.
Rothermundt M, Ohrmann P, Abel S, Siegmund A, Pedersen A, Ponath G . Glial cell activation in a subgroup of patients with schizophrenia indicated by increased S100B serum concentrations and elevated myo-inositol. Prog Neuropsychopharmacol Biol Psychiatry. 2006; 31(2):361-4. DOI: 10.1016/j.pnpbp.2006.09.013. View